Both the agency and its panel of advisors had been concerned about an annual 9.2% rate of pump-related thrombus observed in the nonrandomized ADVANCE trial, which compared the HeartWare device ...
The US Food and Drug Administration (FDA) is notifying physicians of a Class I recall of unimplanted HeartWare ventricular assist device (VAD) implant kits, initiated voluntarily by the company in ...
Thousands of HVADs could have faulty battery cells. Nancy Crotti HeartWare International is recalling more than 18,000 batteries for ventricular assist devices it sold between 2013 and 2015, the ...
Medical technology giant Medtronic plcMDT recently completed the acquisition of HeartWare International, Inc. HTWR - a global medical device manufacturer dedicated to serve patients with advanced ...
After issuing near-monthly safety warnings related to its discontinued HeartWare Ventricular Assist Device (HVAD) last year, Medtronic is already continuing the trend in 2023. The heart pump’s first ...
The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...
A clinical trial of HeartWare's newest LVAD has been paused, at the same time that St. Jude Medical's HeartMate 3 has won CE Mark. Nancy Crotti HeartWare International has put a clinical trial of its ...
(UPDATED) The HeartWare left ventricular assist device (LVAD) may now be used in the United States as a destination therapy in patients with end-stage heart failure who are not candidates for ...
Medtronic has stopped the sale of its Heartware Ventricular Assist Device (HVAD) system and is advising physicians cease implanting the device because problems with an internal pump can lead to death ...
The FDA today approved the HeartWare Ventricular Assist System — a left ventricular assist device — to support heart function and blood flow in patients with end-stage HF who are awaiting a heart ...
HeartWare International Inc. ( HTWR) recently received approval from Health Canada to market its HeartWare Ventricular Assist Device (HVAD) as a bridge to heart transplantation in patients with ...
The HeartWare system is now off the table for left ventricular assist device (LVAD) candidates with advanced heart failure, the FDA announced. Medtronic is halting the global distribution and sale of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results